Chemotherapy declines for breast cancer
Chemotherapy use for early stage breast cancer declined from 2013 to 2015, possibly due to a preference for less toxic treatments, according to researchers at Stanford and the University of Michigan.
New children's hospital opens Dec. 9
The expansion more than doubles the size of the existing pediatric and obstetric hospital campus. With the new building, the hospital will have 361 beds and can serve more patients than ever before.
Faculty get funding from stem cell agency
Three Stanford faculty members were awarded $6 million to support research into a blistering skin disease, transplanted stem cells and novel ways to grow blood stem cells.
Mello on clinical trial reporting
A Stanford professor of law and of health policy discusses the ranking of large pharmaceutical companies based on their sharing of clinical trial information with the public.
Faculty members appointed to endowed professorships
Daniel Chang, Howard Chang, Christopher Garcia, Amy Ladd, William Maloney, Geoffrey Tabin and Jerome Yesavage have been appointed to endowed professorships at the School of Medicine.
Male health condition linked to new risk
Harnessing the power of big data, Stanford researchers found that enlarged veins on the scrotum are linked with a higher risk of vascular and metabolic disease in men.
Stanford to collaborate on Apple Heart Study
The study will make use of an app to determine whether the Apple Watch’s heart-rate sensor can help detect a heart condition known as atrial fibrillation.
Stem cells for fat have circadian clock
New discoveries about the circadian-clock machinery in the precursors to fat cells may explain why shift workers are prone to metabolic diseases, such as diabetes, a Stanford study finds.
Second ‘don’t eat me’ signal found on cancer
CD47 is an important inhibitor of cancer-killing immune cells called macrophages. Now Stanford researchers have identified another, similar way to activate macrophages to destroy cancer cells.
‘Drugs’ from gut bugs
Stanford researchers found that manipulating the gut microbe Clostridium sporogenes changed levels of molecules in the bloodstreams of mice and, in turn, affected their health.